Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sanfetrinem, formerly GV104326, is a new trinem antimicrobial agent with extensive in vitro activity for a variety of different bacteria. The activity of sanfetrinem was determined using a broth microdilution MIC method versus a large number of clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis obtained in a recent 30-center United States surveillance study. The sanfetrinem MIC50 and MIC90 values for these three organism groups were 0.015 and 0.5 microgram/ml, 0.25, and 0.5 microgram/ml, and 0.015 and 0.03, respectively.

Original publication

DOI

10.1016/s0732-8893(96)00173-3

Type

Journal article

Journal

Diagnostic microbiology and infectious disease

Publication Date

09/1996

Volume

26

Pages

39 - 42

Addresses

Clinical Microbiology Laboratories, University of Massachusetts Medical Center, Worcester 01655-0219, USA.

Keywords

Moraxella (Branhamella) catarrhalis, Haemophilus influenzae, Streptococcus pneumoniae, Lactams, Anti-Bacterial Agents, Microbial Sensitivity Tests